Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Predicting neo-adjuvant chemotherapy response from pre-treatment breast magnetic resonance imaging using artificial intelligence and HER2 status

Predicting neo-adjuvant chemotherapy response from pre-treatment breast magnetic resonance imaging using artificial intelligence and HER2 status

US Patent 11983868 · Granted May 14, 2024

Estimated economic value: $360,200,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phenotyping tumor infiltrating lymphocytes on hematoxylin and eosin (H and E) st2025
Batch effect mitigation in digitized images2025
Batch effect mitigation in digitized images2025
Tumor characterization and outcome prediction through quantitative measurements 2025
Tumor characterization and outcome prediction through quantitative measurements 2025
Systems and methods for deep orthogonal fusion for multimodal prognostic biomark2025
Quality control for digital pathology slides2025
Quality control for digital pathology slides2025
Intra-perinodular textural transition (ipris): a three dimenisonal (3D) descript2025
Combination of features from biopsies and scans to predict prognosis in SCLC2024
Computational features of tumor-infiltrating lymphocyte (TIL) architecture2024
Distinguishing colon cancer stages based on computationally derived morphologica2024